Jonathan Noble Selected Research

Hypothyroidism

1/2010

Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan Noble Research Topics

Disease

3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2013 - 08/2006
2	Neoplasms (Cancer) 09/2013 - 08/2006
2	Lung Neoplasms (Lung Cancer) 01/2010 - 08/2006
1	Hypothyroidism 01/2010
1	Hemoptysis 01/2010
1	Hypertension (High Blood Pressure) 01/2010
1	Hand-Foot Syndrome 01/2010
1	Dyspnea (Shortness of Breath) 08/2006
1	Pain (Aches) 08/2006
1	Cough 08/2006

Drug/Important Bio-Agent (IBA)

2	ErbB Receptors (EGF Receptor)IBA 09/2013 - 08/2006
1	Gefitinib (Iressa)FDA Link 09/2013
1	cediranib (AZD2171)IBA 01/2010
1	Carboplatin (JM8)FDA LinkGeneric 01/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2006

Therapy/Procedure

1	Adjuvant Chemotherapy 09/2013
1	Drug Therapy (Chemotherapy) 01/2010
1	Therapeutics 01/2010